Health ❯ Healthcare ❯ Clinical Trials

Vaccine Trials

Efficacy Studies Phase 1 Trials Phase III Trials Triple-Negative Breast Cancer Lung Cancer Vaccine Participant Recruitment Phase I Trials Bundibugyo Vaccine Trial 21-Valent Vaccine Ovarian Cancer Vaccine Trials Late-stage Trials Intercept-Lynch Trial Takeda Biopharmaceuticals Moderna Vaccine Trials Fungal Vaccine Trials QDENGA Trials Qdenga Trials Two-Dose Regimen Moderna Vaccine Safety Monitoring mRNA Vaccines KRAS-targeted Vaccine CMV-based Vaccines Neoantigen Vaccines Phase 3 Trials mFlusiva Trial Allergard Vaccine Trials

KRAS Vaccine Safely Triggers Lasting Immune Response in People at High Risk for Pancreatic Cancer

The small phase 1 trial shows durable KRAS-specific T cells after vaccination with clinical prevention still unproven.

FDA Expands Capvaxive Use to At‑Risk Children and Teens

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

MCRI Launches World-First Infant Trial of 21‑Valent Pneumococcal Vaccine

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial